Abstract
The noninvasive detection of apoptosis, or programmed cell death, is an important biomarker for the severity/progression of diseases and the efficacy of anticancer therapies. In the past decade a rapid expansion in the number of apoptosis imaging agents and techniques offers an increasingly wide selection of approaches for the assessment of apoptosis in vivo. The goal of this review is to provide a general account of existing and emerging apoptosis imaging techniques based on their modes of actions; and to critically discuss the major advantages and obstacles facing the field of apoptosis imaging. In conclusion, tremendous progress has been made in applying the concept of apoptosis imaging toward diagnostic needs. However, for imaging strategies involving exogenous agents, we must recognize the intrinsic distinction between probe density and target density, and appreciate the complexity of apoptosis imaging within the context of probe behaviors in the target tissue. For non-pharmaceutical imaging strategies, there is a continued drive to improve the specificity and applicability of these endogenous markers. Overall, what remains to be addressed, and is critical to clinical translation, is the noninvasive quantification, in addition to detection, of apoptosis in vivo.
Anti-Cancer Agents in Medicinal Chemistry
Title: In Vivo Apoptosis Imaging Agents and Strategies
Volume: 9 Issue: 9
Author(s): Ming Zhao
Affiliation:
Keywords: Apoptosis, imaging, probe
Abstract: The noninvasive detection of apoptosis, or programmed cell death, is an important biomarker for the severity/progression of diseases and the efficacy of anticancer therapies. In the past decade a rapid expansion in the number of apoptosis imaging agents and techniques offers an increasingly wide selection of approaches for the assessment of apoptosis in vivo. The goal of this review is to provide a general account of existing and emerging apoptosis imaging techniques based on their modes of actions; and to critically discuss the major advantages and obstacles facing the field of apoptosis imaging. In conclusion, tremendous progress has been made in applying the concept of apoptosis imaging toward diagnostic needs. However, for imaging strategies involving exogenous agents, we must recognize the intrinsic distinction between probe density and target density, and appreciate the complexity of apoptosis imaging within the context of probe behaviors in the target tissue. For non-pharmaceutical imaging strategies, there is a continued drive to improve the specificity and applicability of these endogenous markers. Overall, what remains to be addressed, and is critical to clinical translation, is the noninvasive quantification, in addition to detection, of apoptosis in vivo.
Export Options
About this article
Cite this article as:
Zhao Ming, In Vivo Apoptosis Imaging Agents and Strategies, Anti-Cancer Agents in Medicinal Chemistry 2009; 9 (9) . https://dx.doi.org/10.2174/187152009789377691
DOI https://dx.doi.org/10.2174/187152009789377691 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
Call for Papers in Thematic Issues
Induction of cell death in cancer cells by modulating telomerase activity using small molecule drugs
Telomeres are distinctive but short stretches present at the corners of chromosomes and aid in stabilizing chromosomal makeup. Resynthesis of telomeres supported by the activity of reverse transcriptase ribonucleoprotein complex telomerase. There is no any telomerase activity in human somatic cells, but the stem cells and germ cells undergone telomerase ...read more
Role of natural compounds as anti anti-cancer agents
Cancer is considered the leading cause of worldwide mortality, accounting for nearly 10 million deaths in 2022. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy remains an important approach in treatment o f several types of cancers, even though ...read more
Signaling and enzymatic modulators in cancer treatment
Cancer accounts for nearly 10 million deaths in 2022 and is considered the leading cause of worldwide mortality. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy, radiotherapy and surgery are the most important approach for the treatment of several ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanofibers Based Tissue Engineering and Drug Delivery Approaches for Myocardial Regeneration
Current Pharmaceutical Design Antioxidant Properties of Nitric Oxide in Cellular Physiological and Pathophysiological Mechanisms. The Implications of Biological Balance between NO and Oxidative Stress
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Vascular Endothelial Function Change in Elderly Chinese Patients with Obstructive Sleep Apnea and its Association with Coronary Heart Disease
Vascular Disease Prevention (Discontinued) Non-pharmacological Modulation of the Autonomic Nervous System for Heart Failure Treatment: Where do We Stand?
Current Vascular Pharmacology Inverse Regulation of MMP-9 and MMP-2 in Long-Term Follow-up After Acute Coronary Syndrome: Lack of Correlation with Platelet and Endothelial Cell Activation Markers
Vascular Disease Prevention (Discontinued) Cardiac Imaging in Heart Failure with Comorbidities
Current Cardiology Reviews Cerebral Angiogenesis and Expression of Angiogenic Factors in Aging Rats after Exercise
Current Neurovascular Research MicroRNA-mediated Regulation of Angiogenesis
Current Angiogenesis (Discontinued) Approaches and Recent Trends in Gene Delivery for Treatment of Atherosclerosis
Recent Patents on Drug Delivery & Formulation CCL2-CCR2 Signaling in Disease Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Your Father and Grandfather’s Atrial Fibrillation: A Review of the Genetics of the Most Common Pathologic Cardiac Dysrhythmia
Current Genomics The Pharmacology of Diabetic Complications
Current Medicinal Chemistry Efficient Expression and Purification of Recombinant Therapeutic Protein Candidates, Human Midkine and Pleiotrophin
Current Pharmaceutical Biotechnology Heart Rate Lowering by Inhibition of the Pacemaker Current: A New Therapeutic Perspective in Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Inflammation and Coronary Artery Disease
Current Vascular Pharmacology The Role of Endothelial Dysfunction in Aortic Aneurysms
Current Pharmaceutical Design Biological Roles of the Eclectic Chromogranin-A-derived Peptide Catestatin
Current Medicinal Chemistry Blood Platelet Reactivity and its Pharmacological Modulation in (People with) Diabetes Mellitus
Current Pharmaceutical Design Ex Vivo Gene Transfer for Improvement of Transplanted Pancreatic Islet Viability and Function
Current Pharmaceutical Design Use of Radiopharmaceuticals for Diagnosis, Treatment, and Follow-Up of Differentiated Thyroid Carcinoma
Anti-Cancer Agents in Medicinal Chemistry